Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000040.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.35 1.28 1.28
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 210.94 560.92 180.39
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.30 7.46 7.48
Cash -3.41 1.00 1.03
Capex 28.20 -0.02 0.01
Free Cash Flow 28.20 -0.02 0.01
Revenue 540.42 0.16 -0.02
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -45.90 0.28 -0.52
Operating Margin -99.16 -0.05 6.14
ROA 92.67 < 0.005 < 0.005
ROE 92.72 < 0.005 -0.02
ROIC 91.67 < 0.005 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000040.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000040.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000040.SZ is permitted for members.